Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
2 "2023"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Validation of 2023 FIGO Stage IA1–IIIC2 Endometrial Carcinoma: A Retrospective Analysis of Two Tertiary Centers in South Korea and Taiwan
Myeong-Seon Kim, Yen-Ling Lai, Yurimi Lee, Hyun-Soo Kim, Yu-Li Chen, Yoo-Young Lee
Received December 11, 2024  Accepted February 10, 2025  Published online February 17, 2025  
DOI: https://doi.org/10.4143/crt.2024.1190    [Accepted]
AbstractAbstract PDF
Purpose
As understanding of the molecular pathogenesis of endometrial carcinoma (EC) advanced, the International Federation of Gynecology and Obstetrics (FIGO) staging system was revised in 2023. This study compared EC survival outcomes using the 2009 and 2023 FIGO staging systems.
Materials and Methods
We retrospectively analyzed 3,029 patients diagnosed with 2009 FIGO stage I–III EC between 1985 and 2022 in South Korea, and between 2020 and 2022 in Taiwan. All patients were reclassified using the 2023 FIGO staging, and survival and risk factors were examined under both systems.
Results
Transitioning from the 2009 to 2023 FIGO resulted in 549 (18.0%) patients being upstaged and their survival curves being diversified, indicating significant prognostic value of the 2023 FIGO. Re-classification using the 2023 FIGO upstaged the 2009 FIGO stage IA high-risk ECs, allowing more intensive treatment and potentially improving survival outcomes. The most significant changes occurred in the 2009 FIGO stages IA, IB, and IIIA ECs: upstaging in 16.5%, 49.0%, and 2.0% of IA, IB, and IIIA tumors, respectively, and downstaging 0.3% and 40.8% of IB and IIIA tumors, respectively. The risk factors for poor survival included old age (≥60), menopause, diabetes, substantial lymphovascular space invasion, aberrant p53 expression, and some aggressive histological types (carcinosarcoma, undifferentiated carcinoma, mesonephric-like adenocarcinoma, and neuroendocrine carcinoma).
Conclusion
The 2023 FIGO staging provides more refined stratification of early-stage EC than the 2009 version. Thus, the 2023 FIGO may more accurately guide prognosis and therapeutic decision-making.
  • 748 View
  • 86 Download
Close layer
Special Article
Prediction of Cancer Incidence and Mortality in Korea, 2023
Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
Cancer Res Treat. 2023;55(2):400-407.
DOI: https://doi.org/10.4143/crt.2023.448
AbstractAbstract PDFPubReaderePub
Purpose
This study aimed to report the projected cancer incidence and mortality for the year 2023 to estimate Korea’s current cancer burden.
Materials and Methods
Cancer incidence data from 1999 to 2020 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2021 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against their respective years and then by multiplying the projected age-specific rates by the anticipated age-specific population for 2023. A joinpoint regression model was used to determine the year in which the linear trend changed significantly; we only used the data of the latest trend.
Results
In total, 273,076 new cancer cases and 81,818 cancer deaths are expected to occur in Korea in 2023. The most common cancer site is expected to be the lung, followed by the thyroid, breast, colon and rectum, and stomach. These five cancers are expected to represent half of the overall burden of cancer in Korea. The most common type of cancer leading to death is expected to be lung cancer, followed by liver, colorectal, pancreatic, and gallbladder cancers.
Conclusion
The incidence rates for all types of cancer in Korea are estimated to gradually decrease. These up-to-date estimates of the cancer burden in Korea could be an important resource for planning and evaluating cancer-control programs.

Citations

Citations to this article as recorded by  
  • A Stool DNA-Based SDC2 Methylation Test for the Early Detection of Colorectal Cancer in an Asymptomatic, High-Risk Population: A Multicenter Prospective Randomized Trial
    Chang Woo Kim, Hyunjin Kim, Hyoung Rae Kim, Daeyeon David Won, Woo Jung Nam, Byung Soh Min, Tae Jeong Oh, Sungwhan An, Suk-Hwan Lee
    American Journal of Gastroenterology.2025; 120(3): 614.     CrossRef
  • Efficacy and safety of herbal medicine treatment on postsurgical recovery in gastric cancer patients: A systematic review and meta-analysis
    Soo-Dam Kim, Sook-Jin Pyo, Dong-Hyeon Kim, Hwa-Seung Yoo, So-Jung Park
    Medicine.2025; 104(1): e41034.     CrossRef
  • The efficacy of second‐line chemotherapy for advanced biliary tract cancer: A systematic review and network meta‐analysis
    Inhwan Hwang, Sangah Han, Ji Hun Jeong, Chunhwa Ihm, Taeho Greg Rhee, Sung Ryul Shim
    Journal of Hepato-Biliary-Pancreatic Sciences.2025; 32(4): 265.     CrossRef
  • Tissue inhibitor of metalloproteinase 1 as a biomarker of venous invasion in pancreatic ductal adenocarcinoma
    You-Na Sung
    American Journal of Cancer Research.2025; 15(3): 1248.     CrossRef
  • Advancements in Cancer Immunotherapy: The Evolution and Future of mRNA and DNA Vaccine Technologies
    Kangchan Choi, Do Hyun Lee, Ji Won Lee, Yong Serk Park
    Biomedical Science Letters.2025; 31(1): 1.     CrossRef
  • Time-trend costs of infection-related cancers in Japan: a systematic review
    Trinh Xuan Thi Nguyen, Sumeet Lal, Sulemana Abdul-Salam
    Discover Public Health.2025;[Epub]     CrossRef
  • A Mediating Effect of Psychological Distress in the Relationship Between Performance Status and Health-Related Quality of Life of Patients with Female Cancer
    Eunha Yeo, JinShil Kim, Jisun Yang, Eun Young Park, Kwang-Hi Park, KyungAh Cho, Seongkum Heo
    Healthcare.2025; 13(9): 1010.     CrossRef
  • Anti-CHI3L1 antibody suppresses colon cancer growth through downregulation of VEGFA and NAMPT expression
    Ji Won Seo, Deok Rim Heo, Ji Eun Yu, A-Young Nam, Na Yeong Lee, Ja Keun Koo, Sang Bae Han, Jung-Hyun Shim, Jin Tae Hong
    Archives of Pharmacal Research.2025; 48(5): 450.     CrossRef
  • Machine learning-derived model for predicting poor post-treatment quality of life in Korean cancer survivors
    Yu Hyeon Choe, Sujee Lee, Yooseok Lim, Soo Hyun Kim
    Supportive Care in Cancer.2024;[Epub]     CrossRef
  • Hormone Replacement Therapy and Risks of Various Cancers in Postmenopausal Women with De Novo or a History of Endometriosis
    Hee Joong Lee, Banghyun Lee, Hangseok Choi, Minkyung Lee, Kyungjin Lee, Tae Kyoung Lee, Sung Ook Hwang, Yong Beom Kim
    Cancers.2024; 16(4): 809.     CrossRef
  • Feasibility of extracting cancer stage and metastasis codes from health insurance claims of outpatients and expressibility in ICD-11: a cross-sectional study using national health insurance data from South Korea
    Young-Taek Park, Dongwoon Han, Kyoung-Hoon Kim, Hoguen Kim, Hojung Joseph Yoon, Chris Lane, Byeo-Ri Kim, Joo-Yeon Jeong
    BMJ Open.2024; 14(2): e073952.     CrossRef
  • A 42-year-old patient with renal cell carcinoma presenting as low back pain: A case report
    Ga Yang Shim, Min-Su Kim, Hong Jun Kim, Yewan Park, So-Woon Kim, Myung Chul Yoo
    Medicine.2024; 103(13): e37639.     CrossRef
  • Biphasic Regulation of Apoptosis Following Gastric Irreversible Electroporation Using Tissue Immunohistochemistry of Activated Caspase-3 with TUNEL Method
    Han Jo Jeon, Hoon Jai Chun, Hyuk Soon Choi, Bora Keum, Hong Bae Kim, Jong Hyuk Kim
    Cancers.2024; 16(7): 1389.     CrossRef
  • Association between Socioecological Status, Nutrient Intake, and Cancer Screening Behaviors in Adults Aged 40 and Over: Insights from the Eighth Korea National Health and Nutrition Examination Survey (KNHANES, 2019)
    Seungpil Jeong, Yean-Jung Choi
    Nutrients.2024; 16(7): 1048.     CrossRef
  • Enhancing registration precision of multispectral breast images by fusing multi-wavelength information based on an improved gradient descent method
    Gang Li, Jiatong Li, Meiling Fan, Nan Su Su Win, Ling Lin
    Biomedical Signal Processing and Control.2024; 96: 106596.     CrossRef
  • Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab after Concurrent Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer: Insights from Real-World Data
    Jeong Yun Jang, Si Yeol Song, Young Seob Shin, Ha Un Kim, Eun Kyung Choi, Sang-We Kim, Jae Cheol Lee, Dae Ho Lee, Chang-Min Choi, Shinkyo Yoon, Su Ssan Kim
    Cancer Research and Treatment.2024; 56(3): 785.     CrossRef
  • Extraperitoneal single-port robot-assisted radical prostatectomy: Short-term outcomes and technique description
    Hyeok Jae Kwon, San Kang, Seung Ah Rhew, Chang Eil Yoon, Dongho Shin, Seokhwan Bang, Hyong Woo Moon, Woong Jin Bae, Hyuk Jin Cho, U-Syn Ha, Ji Youl Lee, Sae Woong Kim, Sung-Hoo Hong
    Investigative and Clinical Urology.2024; 65(5): 442.     CrossRef
  • Diagnostic Accuracy of Contrast-Enhanced Ultrasonography for the Assessment of Small Renal Mass: A Prospective Study
    Jae-Wook Chung, Seo Young Park, Seunghee Woo, Yun Ah Kim, Jun-Koo Kang, Yun-Sok Ha, Jun Nyung Lee, Bum Soo Kim, Tae-Hwan Kim, Ghil Suk Yoon, Tae Gyun Kwon, See Hyung Kim
    Journal of Urologic Oncology.2024; 22(2): 128.     CrossRef
  • Modified Albumin-Bilirubin Grade After Curative Treatment: Predicting the Risk of Late Intrahepatic Recurrence of Hepatocellular Carcinoma
    Myung Ji Goh, Hee Chul Park, Nalee Kim, Bong Kyung Bae, Moon Seok Choi, Jinsoo Rhu, Min Woo Lee, Woo Kyoung Jeong, Minji Kim, Kyunga Kim, Jeong Il Yu
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations
    Eunbin Kwag, Soo-Dam Kim, Seong-Hoon Shin, Chulho Oak, So-Jung Park, Jun-Yong Choi, Seong Hoon Yoon, In-Cheol Kang, Mi-Kyung Jeong, Hyun Woo Lee, Sun-Hwi Bang, Ji Woong Son, Sanghun Lee, Seung Joon Kim, Hwa-Seung Yoo
    Integrative Cancer Therapies.2024;[Epub]     CrossRef
  • Psychometric Characteristics of the Fear of Cancer Recurrence Inventory-Severity Subscale Among Korean Cancer Survivors
    So-Young Park
    Journal of Preventive Medicine and Public Health.2024; 57(4): 319.     CrossRef
  • Symptom burden, palliative care knowledge, and palliative care needs in advanced gynecological cancer patients in Korea
    Eungil Ko, Yaelim Lee
    Supportive Care in Cancer.2024;[Epub]     CrossRef
  • An Antagonist Antibody That Inhibits Cancer Cell Growth In Vitro through RACK1
    Ji Hoe Kim, Eun Ji Lee, Kyung Ho Han
    Pharmaceuticals.2024; 17(10): 1303.     CrossRef
  • Fish and meat intake in relation to colorectal adenoma in asymptomatic Korean adults
    Young Sun Kim, Akinkunmi Paul Okekunle, Sun Young Yang, Ji Hyun Song, Jiyoung Youn, Gabby Yoon Jeong Kwon, Jung Eun Lee
    Frontiers in Nutrition.2024;[Epub]     CrossRef
  • The Past, Present and Future of Imaging Enhanced Endoscopy in Colon Tumor
    Kyueng-Whan Min, One-Zoong Kim
    Journal of Digestive Cancer Research.2024; 12(2): 90.     CrossRef
  • Risk factor analysis and establishment of a predictive model for complications of elderly advanced gastric cancer with Clavien-Dindo classification ≥ II grade
    Zhe-kui Liu, Wen-xing Ma, Jun-jie Zhang, Si-da Liu, Xiang-long Duan, Ze-zheng Wang
    BMC Cancer.2024;[Epub]     CrossRef
  • Social epidemiology of female breast cancer in the region of Varna-Bulgaria in 2013-2021 – A retrospective study
    Galina Yaneva, Tsonka Dimitrova, Oskan Tasinov
    F1000Research.2024; 13: 1137.     CrossRef
  • The Impact of the Dietary Inflammatory Index, Fasting Blood Glucose, and Smoking Status on the Incidence and Survival of Pancreatic Cancer: A Retrospective Case–Control Study and a Prospective Study
    Ga Hyun Lee, Yeon Hee Kim, Sang Myung Woo, Woo Jin Lee, Sung-Sik Han, Sang-Jae Park, Sherry Price, Penias Tembo, James R. Hébert, Mi Kyung Kim
    Nutrients.2024; 16(22): 3941.     CrossRef
  • Gold complexes: a new frontier in the battle against lung cancer
    Aqsa Hanif, Sawsan S. Al-Rawi, Ahmad H. Ibrahim, Abbas Washeel Salman, Ayesha Zafar, Muhammad Adnan Iqbal, Sana Batool, Ghazanfar Abbas
    Reviews in Inorganic Chemistry.2024;[Epub]     CrossRef
  • LuminoMark: An Alternative for Localization
    Ee Jin Kim, Tae Kyung Yoo, Jisun Kim, Il Yong Chung, Beom Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, Sae Byul Lee
    Journal of Surgical Innovation and Education.2024; 1(2): 46.     CrossRef
  • High linc01116 expression may contribute to a poor prognosis in various cancers based on systematic reviews and meta-analyses
    Si-Tong Fan, Dan Li, Qun-Xian Zhang, Li-Qiang Xu, Tao Zeng, Qiang Liu, Qiang Guo, Chen-Yi Lin, Wei-Min Luo
    BMC Cancer.2024;[Epub]     CrossRef
  • Application of Artificial Intelligence to Evaluate Thyroid Nodules
    Jungmin Ahn, Myung-Chul Lee
    Journal of Clinical Otolaryngology Head and Neck Surgery.2023; 34(2): 17.     CrossRef
  • Outcomes of Fertility Preservation for Female Cancer Patients in a Single Tertiary Center
    Ju Hee Kim, Hana Saeed Alzahrani, Sa Ra Lee, Sung Hoon Kim, Hee Dong Chae
    Yonsei Medical Journal.2023; 64(8): 497.     CrossRef
  • Artificial Intelligence in the Pathology of Gastric Cancer
    Sangjoon Choi, Seokhwi Kim
    Journal of Gastric Cancer.2023; 23(3): 410.     CrossRef
  • Role of preoperative immunonutrition in patients with colorectal cancer: a narrative review
    Soo Young Lee, Hyeung-min Park, Chang Hyun Kim, Hyeong Rok Kim
    Annals of Clinical Nutrition and Metabolism.2023; 15(2): 46.     CrossRef
  • Application of Acceptance and Commitment Therapy (ACT) in Hospice and Palliative Care Settings
    So-Young Park
    The Journal of Hospice and Palliative Care.2023; 26(3): 140.     CrossRef
  • Metallothionein Family Proteins as Regulators of Zinc Ions Synergistically Enhance the Anticancer Effect of Cannabidiol in Human Colorectal Cancer Cells
    In-Seo Kwon, Yu-Na Hwang, Ju-Hee Park, Han-Heom Na, Tae-Hyung Kwon, Jin-Sung Park, Keun-Cheol Kim
    International Journal of Molecular Sciences.2023; 24(23): 16621.     CrossRef
  • Scalp nodules as the first presentation of prostate cancer: A CARE-compliant article
    Tae Hoon Oh, Hun Soo Kim, Seung Chol Park
    Medicine.2023; 102(50): e36570.     CrossRef
  • Malignancy in Patients With Inborn Errors of Immunity Beyond Infectious Complication: Single Center Experience for 30 Years
    Doo Ri Kim, Kyung-Ran Kim, Hwanhee Park, Joon-sik Choi, Yoonsun Yoon, Sohee Son, Hee Young Ju, Jihyun Kim, Keon Hee Yoo, Kangmo Ahn, Hee-Jin Kim, Eun-Suk Kang, Junhun Cho, Su Eun Park, Kihyun Kim, Yae-Jean Kim
    Pediatric Infection & Vaccine.2023; 30(3): 129.     CrossRef
  • Genetically determined alcohol consumption and cancer risk in Korea
    Keum Ji Jung, Ji Woo Baek, Sang Yop Shin, Sun Ha Jee
    Epidemiology and Health.2023; 45: e2023077.     CrossRef
  • 20,784 View
  • 505 Download
  • 41 Web of Science
  • 40 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP